Literature DB >> 26014962

Sources, metabolism, and regulation of circulating sphingosine-1-phosphate.

Monika Książek1, Marta Chacińska1, Adrian Chabowski1, Marcin Baranowski1.   

Abstract

Sphingosine-1-phosphate (S1P) is a bioactive sphingolipid that acts either as an intracellular messenger or as a ligand for its membrane receptors. S1P is a normal constituent of blood, where it is found both in plasma and blood cells. Compared with other cell types, sphingolipid metabolism in erythrocytes and platelets has unique features that allow the erythrocytes and platelets to accumulate S1P. In plasma, S1P is bound mainly to HDLs and albumin. Of note, metabolism and biological activity of S1P is to a large extent affected by the type of its carrier. Plasma S1P is characterized by a short half-life, indicating rapid clearance by degradative enzymes and the presence of high-capacity sources involved in maintaining its high concentration. These sources include blood cells, vascular endothelium, and hepatocytes. However, the extent to which each of these contributes to the plasma pool of S1P is a matter of debate. Circulating S1P plays a significant physiological role. It was found to be the key regulator of lymphocyte trafficking, endothelial barrier function, and vascular tone. The purpose of this review is to summarize the present state of knowledge on the metabolism, transport, and origin of plasma S1P, and to discuss the mechanisms regulating its homeostasis in blood.
Copyright © 2015 by the American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  dihydrosphingosine-1-phosphate; endothelial cells; high density lipoprotein; red blood cells; thrombocytes

Mesh:

Substances:

Year:  2015        PMID: 26014962      PMCID: PMC4479332          DOI: 10.1194/jlr.R059543

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  109 in total

1.  Decreased free sphingoid base concentration in the plasma of patients with chronic systolic heart failure.

Authors:  M Knapp; M Baranowski; A Lisowska; W Musiał
Journal:  Adv Med Sci       Date:  2012-06-01       Impact factor: 3.287

2.  Release of sphingosine-1-phosphate from human platelets is dependent on thromboxane formation.

Authors:  T Ulrych; A Böhm; A Polzin; G Daum; R M Nüsing; G Geisslinger; T Hohlfeld; K Schrör; B H Rauch
Journal:  J Thromb Haemost       Date:  2011-04       Impact factor: 5.824

3.  Sphingosine kinase type 1 inhibition reveals rapid turnover of circulating sphingosine 1-phosphate.

Authors:  Yugesh Kharel; Thomas P Mathews; Amanda M Gellett; Jose L Tomsig; Perry C Kennedy; Morgan L Moyer; Timothy L Macdonald; Kevin R Lynch
Journal:  Biochem J       Date:  2011-12-15       Impact factor: 3.857

4.  Sphingosine 1-phosphate breakdown in platelets.

Authors:  Yutaka Yatomi; Soichiro Yamamura; Nobuo Hisano; Kazuhiko Nakahara; Yasuyuki Igarashi; Yukio Ozaki
Journal:  J Biochem       Date:  2004-10       Impact factor: 3.387

5.  Mechanisms of sphingosine and sphingosine 1-phosphate generation in human platelets.

Authors:  Motohiro Tani; Takamitsu Sano; Makoto Ito; Yasuyuki Igarashi
Journal:  J Lipid Res       Date:  2005-08-01       Impact factor: 5.922

6.  Finding a way out: lymphocyte egress from lymphoid organs.

Authors:  Susan R Schwab; Jason G Cyster
Journal:  Nat Immunol       Date:  2007-12       Impact factor: 25.606

7.  Sphingosine-1-phosphate-mediated osteoclast precursor monocyte migration is a critical point of control in antibone-resorptive action of active vitamin D.

Authors:  Junichi Kikuta; Shunsuke Kawamura; Fumie Okiji; Mai Shirazaki; Sadaoki Sakai; Hitoshi Saito; Masaru Ishii
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-08       Impact factor: 11.205

8.  Sphingosine 1-phosphate release from platelets during clot formation: close correlation between platelet count and serum sphingosine 1-phosphate concentration.

Authors:  Yoshikazu Ono; Makoto Kurano; Ryunosuke Ohkawa; Hiromitsu Yokota; Koji Igarashi; Junken Aoki; Minoru Tozuka; Yutaka Yatomi
Journal:  Lipids Health Dis       Date:  2013-02-18       Impact factor: 3.876

9.  Plasma levels of sphingosine 1-phosphate are strongly correlated with haematocrit, but variably restored by red blood cell transfusions.

Authors:  Samy Selim; Manjula Sunkara; Abdelghaffar K Salous; Steve W Leung; Evgeny V Berdyshev; Alison Bailey; Charles L Campbell; Richard Charnigo; Andrew J Morris; Susan S Smyth
Journal:  Clin Sci (Lond)       Date:  2011-12       Impact factor: 6.124

10.  Plasma sphingosine-1-phosphate is elevated in obesity.

Authors:  Greg M Kowalski; Andrew L Carey; Ahrathy Selathurai; Bronwyn A Kingwell; Clinton R Bruce
Journal:  PLoS One       Date:  2013-09-06       Impact factor: 3.240

View more
  42 in total

1.  Vascular modulation through exercise improves chemotherapy efficacy in Ewing sarcoma.

Authors:  Miriam B G Morrell; Claudia Alvarez-Florez; Aiqian Zhang; Eugenie S Kleinerman; Hannah Savage; Enrica Marmonti; Minjeong Park; Angela Shaw; Keri L Schadler
Journal:  Pediatr Blood Cancer       Date:  2019-05-28       Impact factor: 3.167

Review 2.  The emerging alliance of sphingosine-1-phosphate signalling and immune cells: from basic mechanisms to implications in hypertension.

Authors:  Nicholas Don-Doncow; Yun Zhang; Hana Matuskova; Anja Meissner
Journal:  Br J Pharmacol       Date:  2018-07-03       Impact factor: 8.739

3.  In Silico Characterization of Structural Distinctions between Isoforms of Human and Mouse Sphingosine Kinases for Accelerating Drug Discovery.

Authors:  Brittney L Worrell; Anne M Brown; Webster L Santos; David R Bevan
Journal:  J Chem Inf Model       Date:  2019-03-19       Impact factor: 4.956

Review 4.  Malaria link of hypertension: a hidden syndicate of angiotensin II, bradykinin and sphingosine 1-phosphate.

Authors:  Gunanidhi Dhangadamajhi; Shailja Singh
Journal:  Hum Cell       Date:  2021-03-08       Impact factor: 4.174

Review 5.  The role of dihydrosphingolipids in disease.

Authors:  Ruth R Magaye; Feby Savira; Yue Hua; Darren J Kelly; Christopher Reid; Bernard Flynn; Danny Liew; Bing H Wang
Journal:  Cell Mol Life Sci       Date:  2018-12-06       Impact factor: 9.261

6.  Glycans Meet Sphingolipids: Structure-Based Design of Glycan Containing Analogues of a Sphingosine Kinase Inhibitor.

Authors:  Athanasios Papakyriakou; Francesca Cencetti; Elisa Puliti; Laura Morelli; Jacopo Tricomi; Paola Bruni; Federica Compostella; Barbara Richichi
Journal:  ACS Med Chem Lett       Date:  2020-03-30       Impact factor: 4.345

Review 7.  Sphingolipids and Lipoproteins in Health and Metabolic Disorders.

Authors:  Jahangir Iqbal; Meghan T Walsh; Samar M Hammad; M Mahmood Hussain
Journal:  Trends Endocrinol Metab       Date:  2017-04-24       Impact factor: 12.015

8.  A novel approach for measuring sphingosine-1-phosphate and lysophosphatidic acid binding to carrier proteins using monoclonal antibodies and the Kinetic Exclusion Assay.

Authors:  Jonathan K Fleming; Thomas R Glass; Steve J Lackie; Jonathan M Wojciak
Journal:  J Lipid Res       Date:  2016-07-21       Impact factor: 5.922

Review 9.  Nuclear lipid mediators: Role of nuclear sphingolipids and sphingosine-1-phosphate signaling in epigenetic regulation of inflammation and gene expression.

Authors:  Panfeng Fu; David L Ebenezer; Alison W Ha; Vidyani Suryadevara; Anantha Harijith; Viswanathan Natarajan
Journal:  J Cell Biochem       Date:  2018-05-08       Impact factor: 4.429

Review 10.  Cell-Cell Communication Breakdown and Endothelial Dysfunction.

Authors:  Daniel D Lee; Margaret A Schwarz
Journal:  Crit Care Clin       Date:  2020-01-31       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.